Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers.

MLA

Circosta, Paola, et al. “Full Chimaeric CAR.CIK from Patients Engrafted after Allogeneic Haematopoietic Cell Transplant: Feasibility, Anti‐leukaemic Potential and Alloreactivity across Major Human Leukocyte Antigen Barriers.” British Journal of Haematology, vol. 200, no. 1, Jan. 2023, pp. 64–69. EBSCOhost, https://doi.org/10.1111/bjh.18469.

APA

Circosta, P., Donini, C., Gallo, S., Giraudo, L., Gammaitoni, L., Rotolo, R., Galvagno, F., Capellero, S., Basiricò, M., Casucci, M., Aglietta, M., Ferrero, I., Fagioli, F., Cignetti, A., Carnevale, S. F., Leuci, V., & Sangiolo, D. (2023). Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers. British Journal of Haematology, 200(1), 64–69. https://doi.org/10.1111/bjh.18469

Chicago

Circosta, Paola, Chiara Donini, Susanna Gallo, Lidia Giraudo, Loretta Gammaitoni, Ramona Rotolo, Federica Galvagno, et al. 2023. “Full Chimaeric CAR.CIK from Patients Engrafted after Allogeneic Haematopoietic Cell Transplant: Feasibility, Anti‐leukaemic Potential and Alloreactivity across Major Human Leukocyte Antigen Barriers.” British Journal of Haematology 200 (1): 64–69. doi:10.1111/bjh.18469.